These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24464958)

  • 1. How long should we maintain long-term azithromycin treatment in cystic fibrosis patients?
    Willekens J; Eyns H; Malfroot A
    Pediatr Pulmonol; 2015 Jan; 50(1):103-4. PubMed ID: 24464958
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term azithromycin may improve lung function in children with cystic fibrosis.
    Jaffé A; Francis J; Rosenthal M; Bush A
    Lancet; 1998 Feb; 351(9100):420. PubMed ID: 9482305
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of azithromycin in patients with cystic fibrosis.
    Yousef AA; Jaffe A
    Paediatr Respir Rev; 2010 Jun; 11(2):108-14. PubMed ID: 20416547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Has the time come to prescribe azithromycin in cystic fibrosis patients?
    McCormack JG; Bell SC
    Intern Med J; 2005 Feb; 35(2):73-4. PubMed ID: 15705133
    [No Abstract]   [Full Text] [Related]  

  • 5. Do cystic fibrosis patients on azithromycin need electrocardiogram monitoring?
    Sharpton R; Condren M; O'Neal K; Lloyd A; McIntosh H
    Pulm Pharmacol Ther; 2017 Apr; 43():55-56. PubMed ID: 28219728
    [No Abstract]   [Full Text] [Related]  

  • 6. Azithromycin, the multidrug-resistant protein, and cystic fibrosis.
    Altschuler EL
    Lancet; 1998 Apr; 351(9111):1286. PubMed ID: 9643772
    [No Abstract]   [Full Text] [Related]  

  • 7. Azithromycin for cystic fibrosis.
    Southern KW; Barker PM
    Eur Respir J; 2004 Nov; 24(5):834-8. PubMed ID: 15516680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to letter.
    Ratjen F; Anstead M; Lands L; Mayer-Hamblett N; Saiman L
    Pediatr Pulmonol; 2015 Jan; 50(1):105. PubMed ID: 24700677
    [No Abstract]   [Full Text] [Related]  

  • 9. Azithromycin for improving pulmonary function in cystic fibrosis.
    Carr RR; Nahata MC
    Ann Pharmacother; 2004 Sep; 38(9):1520-4. PubMed ID: 15213312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of clinical trials in cystic fibrosis.
    Southern KW; Smyth RL
    Lancet; 2003 Jan; 361(9354):349-50; aurhor reply 350. PubMed ID: 12559892
    [No Abstract]   [Full Text] [Related]  

  • 11. Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial.
    Clement A; Tamalet A; Leroux E; Ravilly S; Fauroux B; Jais JP
    Thorax; 2006 Oct; 61(10):895-902. PubMed ID: 16809416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapidly progressive lung disease in a patient with cystic fibrosis on long-term azithromycin: possible role of mycoplasma infection.
    Janahi IA; Abdulwahab A; Elshafie Sittana S; Bush A
    J Cyst Fibros; 2005 Mar; 4(1):71-3. PubMed ID: 15752685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prolonged use of azithromycin in patients with cystic fibrosis: a meta-analysis.
    Florescu DF; Murphy PJ; Kalil AC
    Pulm Pharmacol Ther; 2009 Dec; 22(6):467-72. PubMed ID: 19328860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.
    Phaff SJ; Tiddens HA; Verbrugh HA; Ott A
    J Antimicrob Chemother; 2006 Apr; 57(4):741-6. PubMed ID: 16469851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-State Therapy with Azithromycin or Low-Dose Prednisolone in Paediatric Cystic Fibrosis Patients: Inflammatory Markers and Disease Progression.
    Shmarina G; Pukhalsky A; Avakian L; Semykin S; Pukhalskaya D; Alioshkin V
    Int Arch Allergy Immunol; 2017; 172(1):45-54. PubMed ID: 28219060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation strategy for potential QTc prolongation with chronic azithromycin therapy in cystic fibrosis.
    Lenehan PJ; Schramm CM; Collins MS
    J Cyst Fibros; 2016 Mar; 15(2):192-5. PubMed ID: 26698953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Macrolides, Pseudomonas aeruginosa and cystic fibrosis].
    Guillot M; Amiour M; El Hachem C; Harchaoui S; Ribault V; Paris C
    Arch Pediatr; 2006 Oct; 13 Suppl 1():S48-50. PubMed ID: 17370396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of treatment response to azithromycin in patients with cystic fibrosis.
    Saiman L; Mayer-Hamblett N; Campbell P; Marshall BC;
    Am J Respir Crit Care Med; 2005 Oct; 172(8):1008-12. PubMed ID: 16040785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin in cystic fibrosis.
    Kastelik JA; Peckham DG; Conway S
    Eur Respir J; 2005 Apr; 25(4):771; author reply 771-2. PubMed ID: 15802355
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-inflammatory therapy in cystic fibrosis].
    Derelle J
    Arch Pediatr; 2003 Sep; 10 Suppl 2():370s-375s. PubMed ID: 14671937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.